A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4244-4248

  Bonello, Laurent ^a,b   Laine, Marc ^a   Baumstarck, Karine ^c   Fernandez, Jessica ^c   Maillard, Luc ^d   Peyrol, Michael ^a   Bessereau, Jacques ^e   Aradi, Daniel ^f   Camilleri, Elise ^g   Roubille, François ^h   Piot, Christophe ^h   Paganelli, Franck ^a   Camoin Jau, Laurence ^c   Dignat George, Françoise ^b,c  

^a HÔPITAL NORD   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Clinique Axium   (France)

^e TIMONE HOSPITAL   (France)

^f UNIVERSITY OF PÉCS   (Hungary)

^g Hôpital de Martigues   (France)

^h HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Acute coronary syndrome; Bleeding; Platelet reactivity monitoring; Stent thrombosis; VASP

Indexed keywords

CLOPIDOGREL; PRASUGREL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH ON TREATMENT PLATELET REACTIVITY; HOSPITAL DISCHARGE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; BLEEDING; PLATELET REACTIVITY MONITORING; STENT THROMBOSIS; VASP;

AGED; BLOOD PLATELETS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; SINGLE-BLIND METHOD; THIOPHENES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84886305756     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.147     Document Type: Article

References (26)

1. M.E. Bertrand, V. Legrand, and J. Boland Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study Circulation 98 1998 1597 1603
2. S. Mehta, S. Yusuf, and R. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
3. L. Bonello, U.S. Tantry, and R. Marcucci Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
4. D. Aradi, A. Komócsi, and A. Vorobcsuk Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis Am Heart J 160 2010 543 551
5. P. Järemo, T.L. Lindahl, and S.G. Fransson Individual variations of platelet inhibition after loading doses of clopidogrel J Intern Med 252 2002 233 238
6. T. Simon, C. Verstuyft, and M. Mary-Krause Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
7. D. Sibbing, W. Koch, and D. Gebhard Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement Circulation 121 2010 512 518
8. D. Sibbing, S. Schulz, and S. Braun Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement J Thromb Haemost 8 2010 250 256
9. P.A. Gurbel, R.C. Becker, K.G. Mann, S.R. Steinhubl, and A.D. Michelson Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834
10. D. Sibbing, S.R. Steinhubl, and S. Schulz Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients. initial evidence of a therapeutic window J Am Coll Cardiol 56 2010 317 318
11. S.D. Wiviott, D. Trenk, and A.L. Frelinger Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation 116 2007 2923 2932
12. A. Sugidachi, T. Ogawa, and A. Kurihara The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite J Thromb Haemost 5 2007 1545 1551
13. L. Bonello, M. Pansieri, and J. Mancini High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473
14. A.D. Michelson, A.L. Frelinger 3rd, and E. Braunwald Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial Eur Heart J 30 2009 1753 1763
15. L. Bonello, J. Mancini, and M. Pansieri Relationship between post-treatment platelet reactivity and ischemic and bleeding events at one year follow-up in patients receiving prasugrel J Thromb Haemost 10 2012 1999 2005
16. L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to VASP phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2010 1404 1411
17. L. Bonello, L. Camoin-Jau, and S. Armero Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol 103 2009 5 10
18. H.J. Bouman, E. Parlak, and J.W. van Werkum Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel J Thromb Haemost 8 2010 482 488
19. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
20. T. Cuisset, C. Frere, and J. Quilici Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study JACC Cardiovasc Interv 1 2008 649 653
21. M. Valgimigli, G. Campo, and N. de Cesare Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study Circulation 119 2009 3215 3222
22. D. Trenk, G.W. Stone, and M. Gawaz A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study J Am Coll Cardiol 59 2012 2159 2164
23. D. Aradi, A. Komócsi, and M.J. Price Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis Int J Cardiol 167 2013 2140 2148
24. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
25. E. Nikolsky, R. Mehran, and H.M. Sadeghi Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial JACC Cardiovasc Interv 2 2009 624 632
26. D.N. Feldman, R.V. Swaminathan, and L.A. Kaltenbach Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012) Circulation 127 2013 2295 2306